Skip to main content
logo
Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
6.19
+0.10 (1.64%)
Sep 29, 2026, 10:50 AM EDT - Market open

Anbio Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2721,320----
Market Cap Growth
-82.28%-----
Enterprise Value
2601,306----
Last Close Price
6.0930.07----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
41.53206.11----
PS Ratio
30.96152.64----
PB Ratio
8.8643.77----
P/TBV Ratio
8.8843.77----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
29.59151.08----
EV/EBIT Ratio
44.36226.50----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.39-0.39-0.68-0.65-0.69-1.65
Asset Turnover
0.350.350.470.452.50-
Quick Ratio
177.13177.137.4111.656.142.06
Current Ratio
344.31344.3110.7115.869.882.07
Return on Equity (ROE)
27.05%27.05%14.83%16.47%132.75%-
Return on Assets (ROA)
14.66%14.66%7.18%8.23%67.52%-
Return on Capital Employed (ROCE)
19.10%19.10%11.60%13.20%81.30%96.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
2.39%0.48%----
Buyback Yield / Dilution
-3.26%-3.26%-97.30%---
SEC Filings: 10-K · 10-Q